material shortage

Genome Analysis

Genome of South Korea purchases CDMO List Labs for $27M

Genome & Company of South Korea has acquired a controlling interest in CDMO List Labs of San Jose, California, for $27 million.

Kevin Dunleavy Sep 9, 2021 10:55am

abecma

Bristol Myers hits Abecma CAR-T manufacturing bottleneck

Jul 28, 2021 10:48am

broken chain

FDA anticipates disruptions, shortages as China outbreak builds

Feb 17, 2020 10:27am